Abstract

A flow of information between lab and clinic enables the Sanford-Burnham Medical Research Institute and the Translational Research Institute for Metabolism and Diabetes to identify better markers for heterogeneous metabolic diseases; a partnership with Takeda is providing proof of principle for the approach.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call